Breast surgical oncologist at Winship Cancer Institute and President-Elect of the Society of Surgical Oncology, known for research on lobular breast cancer and surgical de-escalation.
Tari King is President-Elect of the Society of Surgical Oncology and a breast surgical oncologist at the Winship Cancer Institute of Emory University in Atlanta. Her research addresses invasive lobular carcinoma, ductal carcinoma in situ and the safe de-escalation of breast and axillary surgery. She has led national cooperative group studies in breast surgical oncology.
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, surgical oncology, breast cancer.
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
Shares Society of Surgical Oncology and the tags leadership, clinician-scientist, surgical oncology.
Shares Society of Surgical Oncology, HER2-positive breast cancer, HR-positive / HER2-negative breast cancer.